Henry Schein, Inc. (HSIC)

Henry Schein's stock price has experienced volatility, with a share price of $69.10 as of July 18, 2025, a 2.61% decline from July 22, 2024. Analysts have mixed sentiment, with an average target price of $76.35. The company's earnings for the last quarter were $1.15 per share, exceeding estimations. A major cybersecurity incident in late September 2023 resulted in a significant reduction in Q4 2023 sales and impacted operating income, affecting over 166,000 individuals. The company expects a residual impact of about 15 cents per diluted share and anticipates merchandise sales to remain below pre-incident levels.

The provided search results do not contain explicit information about the demand seasonality for Henry Schein, Inc.'s products and services. Demand for certain medical products might see an increase during periods of higher seasonal illness. The general stability of healthcare services would likely lead to relatively consistent demand, with potential fluctuations based on factors like patient volume, public health trends, and budget cycles of healthcare providers.

Henry Schein, Inc. is a global distributor of healthcare products and services, serving dental and medical practitioners and alternate care sites. The company operates in the Healthcare sector, focusing on Medical Specialties, Healthcare Equipment & Supplies, and Medical Distribution. Their product portfolio includes dental merchandise, equipment, pharmaceuticals, vaccines, surgical products, diagnostic tests, and technology solutions like practice management software and e-commerce solutions. They also manufacture and sell dental implants, biomaterial products, endodontic, orthodontic, and orthopedic products, as well as consumable merchandise under their own brand.

Henry Schein, Inc. has a significant global presence, serving practitioners in over 190 countries and territories. The company has operations or affiliates in 32 countries and territories, with its headquarters in Melville, New York, U.S. Key operational regions include Germany, France, Canada, Switzerland, the UK, and the US. The United States accounts for 69.5% of its net sales. Henry Schein maintains a centralized and automated distribution network with over 300,000 branded and private-brand products.

Henry Schein has maintained a strong brand reputation, being named one of the World's Most Ethical Companies by Ethisphere for the 13th consecutive year. The company has also received the Equality 100 Award and was named to the Fortune World's Most Admired Companies list for 2023. The Science Based Targets initiative (SBTi) approved Henry Schein's emissions reduction targets, verifying its net-zero target by 2050. The major cybersecurity incident in October 2023 negatively affected Henry Schein's reputation, leading to operational disruptions and financial impact. Despite this, Henry Schein emphasized its resilience and commitment to its customers during the recovery process.

Henry Schein, Inc. is primarily owned by institutional shareholders, who hold approximately 95.19% to 104.21% of the company's stock. Individual investors hold a smaller percentage, around 0.00% to 41.70%, and insiders own about 1.14% to 5.27%. Major institutional owners include Vanguard Group Inc., Kohlberg Kravis Roberts & Co. L.P., and BlackRock, Inc. The largest individual shareholder is Stanley M. Bergman, who owns 3.16 million shares, representing 2.60% of the company.